Fred Craves
Managing director and founder
Dermira
United States of America
Biography
Dr. Craves has been a director of Dermira since 2010. He is an investment partner, a Managing Director and a co-founder of Bay City Capital (BCC), and has served as a member of the board of directors and Chairman of the executive committee of BCC since June 1997. Prior to founding BCC, he founded Burrill & Craves, a merchant bank focused on biotechnology and emerging pharmaceutical companies. Dr. Craves served as Executive Vice President of Schering Berlin, Inc. and Chief Executive Officer and President of Berlex Laboratories, Inc. He was also the founding Chairman of the board of directors and Chief Executive Officer of Codon Devices, Inc. and co-founder of Creative Biomolecules. Dr. Craves is currently a member of the boards of directors of Madrigal Pharmaceuticals, Reset Therapeutics and Twist Bioscience. He previously served as a member of the boards of directors of VIA Pharmaceuticals, Inc. and Poniard Pharmaceuticals, Inc. He currently serves as a member of The J. David Gladstone Institutes’ Advisory Council. Dr. Craves earned a B.S. in biology from Georgetown University, an M.S. in biochemical pharmacology from Wayne State University, and a Ph.D. in pharmacology and experimental toxicology from the University of California, San Francisco.
Research Interest
Dermatology